Moore recognized with AACR Minorities in Cancer Research award
Dr. Justin Xavier Moore has been recognized with an American Association for Cancer Research Minorities in Cancer Research award.
The Georgia Cancer Center M. Bert Storey Research Building provides quality research space to promote multidisciplinary collaborations and translational research, which is essential to creating an environment that promotes innovation.
Our research approach supports important National Cancer Institute goals:
Ensuring every cancer patient has access to the newest and most innovative clinical trials in the nation
The main building houses the basic science teams with four floors of open concept-lab space, shared resources and special equipment, such as flow cytometry, radiation therapy research platforms and quantitative pathology imaging as well as administrative offices and meeting spaces for seminars, lectures, training sessions and community-wide forums on cancer-related topics.
The Collaborator Corridor is a new addition designed to facilitate communication and collaboration between cancer researchers and clinicians, with a goal of promoting translational research in order to develop the next generation of cancer diagnostics and treatments.
Georgia Cancer Center Research Programs
Health Sciences Campus
Georgia Cancer Center - M. Bert Storey Research Building
1410 Laney Walker Boulevard
Augusta, GA 30912
Research at the Georgia Cancer Center’s M. Bert Storey Research Building focuses on the most promising pathways for the prevention and treatment of cancer. Several of our researchers are involved with investigator-initiated clinical trials, transitioning their research into the clinic.
Cancer Immunology, Inflammation and Tolerance
The principal goals of the program are to elucidate molecular pathways and cellular processes active in tumor microenvironments in order to develop, characterize, and apply immunological approaches to prevention, diagnosis, treatment, and monitoring of premalignant and malignant diseases.
Cancer Prevention, Control and Population Health
Each member of the Cancer Prevention, Control & Population Health Program reaches out to community organizations, schools and other civic groups to promote the importance of prevention, early detection and regular screenings and particularly in addressing, can health disparities and health equity.
Molecular Oncology and Biomarkers
The overall goals of this program are to understand the fundamental cellular and molecular processes that contribute to cancer development and progression. The research interests of the program can be divided into three broad themes: Cancer Genetics, Epigenetics, and Chaperone Biology.
Tumor Signaling and Angiogenesis
The unifying theme of this program is to build translational clinical trials based on innovative and novel research projects that focus on signaling cascades leading to uncontrolled cell growth and resistance to apoptosis. The program goals are to identify dysregulated molecular signaling pathways that can be used as cancer-specific targets.
The Georgia Cancer Center supports shared research resources and facilities providing important support to members of the Cancer Center and their collaborators. The various resources offer access to state-of-the-art technology and computational support at an affordable cost.
The Georgia Cancer Center provides dedicated support to its researchers for the writing and submission of extramural and intramural grant applications.
Learn more about the basic scientists working at the Georgia Cancer Center and how their work could advance the future of cancer research.
The PRMC provides internal scientific review for all new cancer-related clinical research studies within the Georgia Cancer Center.
Dr. Justin Xavier Moore has been recognized with an American Association for Cancer Research Minorities in Cancer Research award.
"Colon cancer is largely preventable if patients undergo screening tests, like a surveillance colonoscopy starting at 45 years or earlier depending on family history."
Despite liver cancer being the third leading cause of cancer deaths worldwide, there are not many treatment options currently available for patients. Dr. Yukai He and his team want to change that.
This year’s fundraising total represents a 65% increase since its inaugural event held in May 2019.
We provide instruction classes and research assistance in person and electronically.
